Is Ergothioneine Skin Health Randomized Trial safe?

The current Migaku evidence database contains 2 reusable source documents for Ergothioneine Skin Health Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - Nevertheless, the procedure carries a potential risk of post&#8208;inflammatory hyperpigmentation (PIH) [], especially among individuals with Fitzpatrick skin type IV, which is prevalent in the Chinese population []. [He Yixuan (2026); evidence level 2] - 1 At the end of the study, the efficacy rates for all symptoms were found to be higher on the test sides than on the control sides (Figure&#160;). [He Yixuan (2026); evidence level 2] - p p p p Because of postoperative edema, SCH values were significantly increased on both sides at T3d compared with baseline (both&#8201;<&#8201;0.001), indicating a transiently compromised skin barrier, and returned to baseline levels by T8d. [He Yixuan (2026); evidence level 2] - EI HA MAPK MI NF&#8208;&#954;B NO Nrf2 PIH SCH SE SSRI TEWL TNF&#8208;&#945; 1 2 3 4 5 In recent years, skin photoaging has received increasing attention. [He Yixuan (2026); evidence level 2] - Current Evidence of Ergogenic and Post-Exercise Recovery Effects of Dietary Supplementation with Cordyceps militaris in Humans—A Narrative Review [Jędrejko M (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.